MINI FUTURE LONG - BALCHEM CO. Share Price

Certificat

DE000ME5AY15

Delayed Börse Stuttgart 20:44:19 28/05/2024 BST
2 EUR -3.38% Intraday chart for MINI FUTURE LONG - BALCHEM CO.
Current month+75.44%
1 month+112.77%
Date Price Change
28/05/24 2 -3.38%
27/05/24 2.07 -5.05%
24/05/24 2.18 +1.40%
23/05/24 2.15 -8.90%
22/05/24 2.36 -2.07%

Delayed Quote Börse Stuttgart

Last update May 28, 2024 at 08:44 pm

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying BALCHEM CORPORATION
Issuer Morgan Stanley
WKN ME5AY1
ISINDE000ME5AY15
Date issued 13/12/2023
Strike 130.3 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.91
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.9
Lowest since issue 0.75

Company Profile

Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company's segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. Through Specialty Products, it re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Sector
-
More about the company

Ratings for Balchem Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Balchem Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
152 USD
Average target price
166 USD
Spread / Average Target
+9.19%
Consensus